Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...

In the early 1980s, a hit TV show introduced many Americans to artificial intelligence (AI). While Michael Knight ... new AI-based approaches in disease biology modeling, in silico drug design, and ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

The drug was much quicker to market than ones developed in more traditional ways A drug molecule "invented" by artificial intelligence (AI) will be used in human trials in a world first for ...

Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule inhibitor. Currently referred to as ISM001-055, the drug is meant to ...

Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that showed promise in a new drug for treating inflammatory bowel disease ...